Indefinite Delivery Contract 36C26223D0011
Award Date
12/1/22
Last Date to Order
11/30/25
Federal Agency
Veterans Integrated Service Network 22
Awardee
JRS Pharma LP
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $29,031,544.57 IDC covers the delivery of a wide range of branded and generic pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service through August 2029. Key items include medications such as ibuprofen, citalopram, albuterol,...
The Department of Veterans Affairs (VA) awarded Prasco, LLC, a pharmaceutical company based in Mason, Ohio, a single-award Indefinite Delivery Contract (IDC) valued at $31,715,011.75. This contract, which runs through June 4, 2034, allows Prasco to manufacture and distribute a range of pharmaceutical products to support VA healthcare programs. Additionally, Prasco holds a multiple-award Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), also awarded by the VA, with a...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Avkare LLC, a pharmaceutical and medical supply company, to provide a wide range of pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a total ceiling value of $12,991,472.85 and a period of performance from March 16, 2020 to March 15, 2025. It was awarded as a...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of the...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $40,480,225.15 and a period of performance from February 12, 2022 to February 11, 2023, with four one-year option periods. The contract was awarded to provide an uninterrupted supply of various strengths and package sizes of...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026. The contract will supply aripiprazole tablets in various package sizes to the VA,...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a single-award Indefinite Delivery Contract (IDC) to Wells Pharma of Houston LLC, a for-profit limited liability company, to provide 503B compounding pharmaceuticals. The IDC has a ceiling value of $441,181 and a performance period through September 2025, with no set-aside designation. As part of this IDC, the VA has issued two delivery orders to Wells Pharma: a $220,590.50 order in February 2024 and a $97,340.50...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The contract, valued at $14,155,681.05, is for the supply of ezetimibe tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The period of performance is one year with four one-year option periods, running from April 28, 2024 to...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The IDC has a ceiling value of $7,656,786.70 and a period of performance from June 3, 2025 to June 2, 2026, with four one-year option periods. The contract primarily consists of 6 line items for the delivery of Cyclobenzaprine HCL Tablets in various package sizes, including 30,...